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Purpose: The aim of this study was to compare the quality of consent process in refractive 
surgery between patients who had a preoperative consent discussion with the surgeon using a 
telemedicine approach and those who had a face-to-face discussion.
Methods: Patients treated between January and December 2017 (8,184 laser vision correction 
[LVC] and 3,754 refractive lens exchange [RLE] patients) that attended day 1 and 1-month 
postoperative visit were retrospectively reviewed. Preoperative consent preparation included a 
consultation with an optometrist, observation of an educational video, and written information. 
Patients then selected either a face-to-face appointment with their surgeon (in-clinic group) 
or a telemedicine appointment (remote group) for their consent discussion, according to their 
preference. Patient experience questionnaire and clinical data were included in a multivariate 
model to explore factors associated with consent quality.
Results: Prior to surgery, 80.1% of LVC and 47.9% of RLE patients selected remote consent. 
Of all LVC patients, 97.5% of in-clinic and 98.3% of remote patients responded that they were 
adequately consented for surgery (P=0.04). Similar percentages in the RLE group were 97.6% 
for in-clinic and 97.9% for remote patients (P=0.47). In a multivariate model, the major predic-
tor of patient’s satisfaction with the consent process was postoperative satisfaction with visual 
acuity, responsible for 80.4% of variance explained by the model. Other significant contributors 
were postoperative visual phenomena and dry eyes, difficulty with night driving, close-up and 
distance vision, postoperative uncorrected distance visual acuity, change in corrected distance 
visual acuity, and satisfaction with the surgeon’s approach. The type of consent (remote or in-
clinic) had no impact on patient’s perception of consent quality in the regression model.
Conclusion: The majority of patients opted for telemedicine-assisted consent. Those who 
chose it were equally satisfied as those who had a face-to-face meeting with their surgeon. 
Dissatisfaction with surgical outcome was the major factor affecting patient’s perception of 
consent quality, regardless of the method of their consent.
Keywords: informed consent, telemedicine, refractive surgery, LASIK, photorefractive 
keratectomy, refractive lens exchange
Introduction
Telemedicine is defined as the use of telecommunication and information technology 
to provide clinical health care from a distance.1 With improvements in technology, 
Internet, and transfer of information, telemedicine has become established in numerous 
areas of medicine. This includes multiple areas of health care delivery: consenting, 
achieving a diagnosis, instituting treatment, disease prevention, and medical research.1–3 
In ophthalmology, telemedicine (or “teleophthalmology”) has been used mainly for 
screening for glaucoma, cataract, or retinal diseases, providing patients in rural and 
remote areas with improved access to eye care.2,4–6 There have also been some recent 
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reports of using teleophthalmology as a therapeutic, rather 
than just diagnostic tool (eg, teleophthalmology navigated 
retinal laser therapy), which could have great potential 
for the future.7
In one of our previous publications, we discussed the 
consent process for elective refractive surgery, the role of 
the treating surgeon in the consenting process, and examined 
if meeting the surgeon prior to the surgery or on the day of 
surgery affects the patient’s perception of consent quality.8 
We also explored how the consent process can be enhanced 
with the use of different tools such as video consent, written 
information, and the involvement of medical personnel other 
than the treating surgeon.8 Since our last publication, new 
UK General Medical Council guidelines were published 
and came into effect in June 2016. These require doctors 
performing cosmetic or refractive interventions to discuss 
the procedure with their patient ahead of the day of surgery.9 
This prompted us to change our consenting approach: each 
patient is required to discuss the procedure with their treating 
surgeon prior to the day of surgery. Patients have an option 
to either discuss the procedure remotely (telemedicine) or to 
have a face-to-face meeting with their surgeon prior to the 
day of surgery. Each patient, whether they elect to speak to 
their surgeon via a telemedicine or face-to-face meeting 
approach, has to undergo a face-to-face examination on the 
day of surgery prior to any procedure taking place. During 
this examination, the treating surgeon and patient complete 
the informed consent process. The aim of this study was to 
investigate whether these two methods of consenting (remote 
or in-clinic) have an impact on the patient’s perception of 
consent quality.
Patients and methods
All patients provided informed consent to undergo refractive 
surgery (LASIK, photorefractive keratometry [PRK], or 
refractive lens exchange [RLE]). As a part of their consent 
process, all patients involved in the study agreed for their 
data to be used (without patient’s identifiers) for statistical 
analysis and research. The study was deemed exempt from 
full review by the Committee on Human Research at the 
University of California, San Francisco because it used only 
retrospective, de-identified patient data, and followed the 
principles of the Declaration of Helsinki.
Clinical data and patient questionnaire outcomes were 
exported from Optical Express electronic medical records 
for all patients who underwent laser vision correction (LVC) 
or RLE (corrected distance visual acuity [CDVA] not worse 
than 20/40) between January and December 2017, attended 
day 1 and 1-month postoperative follow-up visit, and 
completed a questionnaire.
Patients first underwent a preoperative consultation 
with an experienced refractive optometrist in their local 
clinic, which involved clinical examination, discussion, 
and diagnostic measurements. The refractive optometrist 
first assessed the patient’s medical and ocular history, 
occupation, hobbies, and general expectations from refractive 
surgery. The clinical examination involved a manifest 
refraction, cycloplegic refraction, uncorrected distance 
visual acuity (UDVA) and CDVA, external ocular exam, 
ocular motility, confrontational visual fields, biomicroscopic 
exam, dilated fundoscopy, and diagnostic scans (corneal 
topography: Pentacam; Oculus Inc., Arlington, WA, USA; 
wavefront aberrometry: iDesign Advanced Wave Scan 
System; Johnson & Johnson Vision Care, Inc, Jacksonville, 
FL, USA; noncontact tonometry/autorefraction).
Based on the consultation, the optometrist made a 
preliminary determination of whether the patient met all 
the suitability criteria for refractive surgery and discussed 
the most appropriate procedure (LASIK, PRK, or RLE). 
The optometrist then discussed the benefits of the proposed 
surgery, possible complications, side effects, and postoperative 
expectations, and answered all the patient’s questions. The 
patient was also provided written information consisting of 
the informed consent document, information about the proce-
dure, preoperative preparation, and postoperative aftercare.
All patients watched an educational video, which reiter-
ated all the points discussed with the optometrist. At the con-
clusion of the video, the patient and the optometrist completed 
an electronic signature section within the Electronic Medical 
Records system to confirm the patient’s understanding of the 
proposed procedure, potential risks, and range of associated 
outcomes in addition to the benefits and alternatives. RLE 
candidates had a detailed discussion about intraocular lens 
types and their possible side effects and underwent further 
diagnostic tests (biometry for lens calculation: IOLMaster; 
Carl Zeiss Meditec AG, Jena, Germany; retinal optical 
coherence tomography: Cirrus 4000/500 OCT; Carl Zeiss 
Meditec AG; and specular microscopy: SP 2000P specular 
microscope; Topcon Europe BV, Tokyo, Japan).
All patients then had an option to either meet their surgeon 
prior to the day of surgery in person (“in-clinic” group) or to 
arrange a telephone discussion with the surgeon (“remote” 
group). Patient’s choice determined the type of consent, but 
there was a small group of patients with certain conditions 
that were required to attend in-clinic consent, and these 
patients were excluded from this study. In-clinic consent 
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was necessary in all patients (RLE and LVC) with significant 
corneal scars (CDVA #20/25), corneal dystrophy (Fuchs, 
guttata, map-dot-fingerprint dystrophy, etc), family history 
of keratoconus, and any suspicious corneal shape (superior–
inferior keratometry difference on Pentacam saggital map 
[4 mm diameter] .1.4 D or any other signs of abnormal or 
irregular topography). Additionally, for RLE patients, it was 
mandatory to attend in-clinic consent if they: were younger 
than 50 years with myopia .6.0 D, were younger than 
40 years (regardless of the refractive error), had low distance 
prescription presbyopes (defined as UDVA of 20/25 or better 
in each eye), and had retinal pathology reducing CDVA 
to #20/25 (eg, signs of age-related macular degeneration, 
drusen, epiretinal membrane, etc).
All patients who participated in an in-clinic consent had 
a discussion and ophthalmic examination performed by 
their surgeon on the day of their consultation and a further 
examination performed on the day of surgery. All patients 
in the remote group had a discussion with the surgeon over 
the phone and an ophthalmic examination performed by the 
treating surgeon on the day of surgery. Prior to the remote 
discussion, surgeons had access to the patient’s electronic 
file and reviewed outcomes of all scans and measurements 
obtained by the optometrist in their local clinic. In both cases 
(in-clinic and remote), patients were encouraged to have their 
consent discussion at least 7 days prior to surgery, and if this 
was not possible, a minimum 48-hour reflection period was 
required. Each step of the consent process (discussion with an 
optometrist, video consent, discussion with the surgeon) cul-
minated in signing an electronic declaration, where the patient 
confirmed understanding all main points of the discussion. 
Patient who had a remote consent discussion received a web 
link asking them to confirm that the discussion took place.
Except for patients with known conditions described 
above, patients could choose between the two types of 
consent (in-clinic or remote); however, they were always 
encouraged to meet their surgeon ahead of the day of surgery 
and this appointment did not incur any extra cost.
Postoperatively, patients were scheduled for 1-day, 
1-week, and 1-month follow-up visits were they were clinically 
examined and completed a postoperative questionnaire. 
The methodology of obtaining the questionnaire has been 
previously described.8 The questionnaire was strictly 
confidential, and patients were informed that their responses 
were not made available to the treating surgeon and were 
not accessible to any clinic personnel. All questions from 
the patient questionnaire used for statistical analysis are 
listed in Table 1.
statistical analysis
All calculations and statistical analysis were performed using 
SAS 9.3 (SAS Institute Inc., Cary, NC, USA) and Microsoft 
Office Excel 11.0 (Microsoft Corporation, Redmond, WA, 
USA) software. Preoperative and 1-month postoperative 
data between in-clinic and remote groups of patients were 
compared using an unpaired t-test and a chi-squared test was 
applied for the comparison of percentages.
A multivariate regression model was developed to 
find independent predictors of the outcomes of question 
3 (Table 1): “Do you feel you were properly consented for 
surgery?” Variables included in the regression model were 
patients demographics (age, gender), preoperative and 
postoperative clinical data (visual acuity, refractive error), 
questionnaire outcomes (Table 1), type of consent (in-clinic 
vs remote), as well as the number of days between the consent 
appointment and surgery day. The model was developed 
using a stepwise generalized linear approach. Detailed steps 
in model creation have been previously described.8
Results
Of all patients, 19.9% of LVC patients and 52.1% of RLE 
patients preferred to meet their treating surgeon ahead of 
the day of surgery, whereas 80.1% of LVC patients and 
47.9% of RLE patients opted for a remote consent discus-
sion. Tables 2 (LVC) and 3 (RLE) compare preoperative 
and 1-month postoperative clinical parameters between 
in-clinic and remote groups of patients. Patients who opted 
to meet their treating surgeon ahead of the day of surgery 
were slightly older and tended to have higher preoperative 
myopic sphere, higher cylinder, and slightly worse pre-
operative CDVA (Tables 2 and 3). As expected (due to 
higher levels of preoperative ametropia), most of the mean 
postoperative outcomes were worse for patients with in-
clinic consent.
Postoperative day 1 questionnaire
On the first postoperative day, 99.6% of in-clinic LVC 
patients and 99.3% of remote patients (P=0.21) responded 
by confirming that they were either satisfied or very satisfied 
with the surgeon’s care (question 1, Table 1). In the RLE 
group, these percentages were 99.5% and 99.6% for in-clinic 
and remote groups, respectively (P=0.82).
Most of the patients in the LVC group (98.9% of in-clinic 
patients vs 99.1% of remote patients; P=0.64) and RLE group 
(99.1% in-clinic and 99.4% remote; P=0.30) were satisfied 
or very satisfied that their surgeon answered all of their ques-
tions (question 2, Table 1).
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Table 2 Preoperative and 1-month postoperative clinical outcomes of laser vision correction patients
Clinical/demographic variable Consent type P-value
In-clinic Remote
number of patients 1,626 6,558 –
Female/male ratio 45.8%/54.2% 47.4%/52.6% 0.23
agea 34.4±10.8 (18–66) 33.8±10 (18–66) 0.03
Preoperative dataa
sphere, D
Myopic sphere −3.05±2.06 −2.77±1.84 ,0.01
hyperopic sphere +1.37±0.95 +1.46±0.97 0.15
range (−11.25 to +4.75) (−11.00 to +4.75)
Cylinder, D −0.87±0.85 (0.00 to −6.00) −0.78±0.72 (0.00 to −6.00) ,0.01
CDVa, logMar −0.06±0.06 (0.3 to −0.18) −0.07±0.05 (0.3 to −0.3) ,0.01
One-month postoperative dataa
sphere, D +0.05±0.43 (+2.50 to −3.00) +0.07±0.39 (+2.50 to −3.25) 0.01
Cylinder, D −0.23±0.30 (0 to −3.25) −0.20±0.26 (0 to −3.50) ,0.01
CDVa, logMar −0.08±0.06 (0.3 to −0.3) −0.09±0.06 (0.52 to −0.3) ,0.01
Binocular UDVa, logMar −0.11±0.08 (0.52 to −0.3) −0.09±0.09 (0.7 to −0.3) ,0.01
Note: aThese values are given as mean ± sD or mean ± sD (range).
Abbreviations: CDVa, corrected distance visual acuity; UDVa, uncorrected distance visual acuity.
Table 1 Patient experience questionnaire
Postoperative day 1 questionnaire
Question 1. Overall how satisfied are you with the care that was provided by the surgeon?
(1= very satisfied, 2= satisfied, 3= neither, 4= dissatisfied, 5= very dissatisfied)
Question 2. Overall how satisfied are you that the surgeon answered all of your questions?
(1= very satisfied, 2= satisfied, 3= neither, 4= dissatisfied, 5= very dissatisfied)
One-month postoperative questionnaire
Question 3. Do you feel you were properly consented for surgery?
(1= yes, 2= no)
Question 4. Thinking about your vision during the last week, how satisfied are you with your vision (without the use of glasses or contact lenses)?
(1= very satisfied, 2= satisfied, 3= neither, 4= dissatisfied, 5= very dissatisfied)
Question 5. Would you recommend vision correction surgery to your friends and relatives?
(1= yes, 2= no)
Question 6. Think about your vision during the last week.  
Please rate the degree of difficulty you experienced with:
•	 starburst
•	 glare
•	 halos
•	 ghosting/double vision
•	 dry eyes
(Measured on a discrete scale from 1= no difficulty to 7= severe difficulty)
Question 7. Because of your eyesight, how much difficulty do you have with driving at night?
(1= no difficulty, 2= a little difficulty, 3= moderate difficulty, 4= a lot of difficulty, 5= never try to do this because of my vision, 6= never do this for 
other reasons)
Question 8. Because of your eyesight, how much difficulty do you have in doing work or hobbies that require you to see well up close, such as 
cooking, fixing things around the house, sewing, using hand tools, or working with a computer?
(1= no difficulty, 2= a little difficulty, 3= moderate difficulty, 4= a lot of difficulty, 5= never try to do this because of my vision, 6= never do this for 
other reasons)
Question 9. Because of your eyesight, how much difficulty do you have in taking part in active sports or other outdoor activities that you enjoy 
(like hiking, swimming, aerobics, team sports, or jogging)?
(1= no difficulty, 2= a little difficulty, 3= moderate difficulty, 4= a lot of difficulty, 5= never try to do this because of my vision, 6= never do this for 
other reasons)
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Table 3 Preoperative and 1-month postoperative clinical outcomes of refractive lens exchange patients
Clinical/demographic variable Consent type P-value
In-clinic Remote
number of patients 1,954 1,800 –
Female/male ratio 46.6%/53.4% 46.9%/53.1% 0.86
agea 59.6±8.8 (19–88) 58.3±7.4 (21–85) ,0.01
Preoperative dataa
sphere, D
Myopic sphere −3.87±3.34 −2.83±2.23 ,0.01
hyperopic sphere +2.44±1.69 +2.37±1.44 0.06
range (−16.75 to +10.75) (−15.75 to +10.25)
Cylinder, D −0.79±0.74 (0 to −6.75) −0.62±0.55 (0 to −6.50) ,0.01
CDVa, logMar −0.02±0.09 (0.3 to −0.18) −0.04±0.07 (0.3 to −0.18) ,0.01
One-month postoperative dataa
sphere, D +0.03±0.51 (+2.00 to −3.25) +0.06±0.51 (+2.50 to −3.25) 0.003
Cylinder, D −0.45±0.44 (0 to −4.00) −0.43±0.40 (0 to −4.00) 0.05
CDVa, logMar −0.04±0.07 (0.7 to −0.18) −0.05±0.07 (0.52 to −0.3) ,0.01
Binocular UDVa, logMar −0.03±0.10 (0.7 to −0.18) −0.04±0.10 (0.6 to −0.18) ,0.01
Note: aThese values are given as mean ± sD or mean ± sD (range).
Abbreviations: CDVa, corrected distance visual acuity; UDVa, uncorrected distance visual acuity.
One-month postoperative questionnaire
In the LVC group, 97.5% of in-clinic patients and 98.3% 
of remote patients stated they were properly consented for 
surgery (question 3) and this slight difference was statisti-
cally significant (P=0.04). Likewise, the percentages for the 
RLE group were 97.6% for in-clinic and 97.9% for remote 
patients (P=0.47).
Figure 1 depicts the postoperative satisfaction with 
vision (Table 1, question 4). At the 1-month postoperative 
aftercare visit, 94.0% of in-clinic and 94.7% of remote 
Figure 1 Postoperative satisfaction with visual acuity: patients who had a remote consent discussion with their surgeon vs patients who had a face-to-face discussion in the clinic.
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Table 4 Visual phenomena and dry eyes
Postoperative 
symptoms
Postoperative mean score
(mean ± SD)
In-clinic Remote P-value
laser vision correction
number of patients 1,626 6,558
starburst 1.58±1.13 1.59±1.16 0.75
glare 1.65±1.14 1.67±1.16 0.62
halo 1.57±1.12 1.55±1.10 0.63
ghosting/double vision 1.34±0.93 1.25±0.79 0.0006
Dry eyes 1.96±1.31 1.96±1.29 0.99
refractive lens exchange
number of patients 1,954 1,800
starburst 1.85±1.41 1.89±1.51 0.47
glare 1.96±1.40 1.96±1.48 0.93
halo 2.00±1.53 2.00±1.58 0.91
ghosting/double vision 1.35±0.93 1.37±0.99 0.54
Dry eyes 1.77±1.23 1.79±1.24 0.60
Note: Each patient rated visual phenomena/dry eye difficulties on a scale from 
1 (= no difficulty) to 7 (= severe difficulty) and the mean score for all patients was 
calculated.
LVC patients were “satisfied” (very satisfied or satisfied) 
with their vision. For RLE patients, these percentages were 
90.3% for the in-clinic group and 90.0% for the remote 
group. There was no statistically significant difference in 
postoperative satisfaction between the in-clinic and remote 
patients (Figure 1).
Of all LVC patients, 96.0% and 97.0% of in-clinic and 
remote patients, respectively (P=0.05), were willing to rec-
ommend the surgery to their friends or relatives (question 5). 
These percentages were 94.7% for in-clinic and 95.3% for 
the remote group for RLE patients.
Table 4 summarizes the mean postoperative scores for 
optical side effects and dry eye (question 6). There was no 
statistically significant difference between in-clinic and 
remote patients in any questioned side effect, except for a 
slight difference in ghosting for LVC patients.
Figure 2A and B shows the difficulties patients expe-
rienced with various activities (night driving, near vision, 
or distance tasks; questions 7–9 from Table 1). Again, 
no statistically significant difference was found in the 
outcomes of questions 7–9 between in-clinic and remote 
patients.
Multivariate model
Table 5 presents the outcomes of the regression model 
to predict the response to the question: “Do you feel you 
were properly consented for surgery?” RLE and LVC data 
were combined into one model to create a stronger data set. 
Initially, we explored two separate regression models for 
RLE and LVC, but the same predictive factors were found 
in both cases.
Question 4 (postoperative satisfaction with vision) was 
the major predictor of patient’s perception of consent quality, 
and it was responsible for 80.4% of the variance explained 
by the regression model. Figure 3 shows the percentage of 
patients who were “very satisfied/satisfied”, “neither satisfied 
nor dissatisfied”, or “very dissatisfied/dissatisfied” with their 
postoperative visual outcomes for patients who felt consented 
properly, and those who did not feel properly consented. Of 
all patients who did not feel that they were properly consented 
for their refractive procedure, 32.5% were dissatisfied with 
the postoperative vision, while only 2.6% of patients were 
dissatisfied in the group of patients who indicated they were 
properly consented.
Postoperative visual phenomena (5.8% variance 
explained, question 6 from Table 1) and dry eye symp-
toms (1.0% variance explained) were the other statistically 
significant factors predicting the consent quality perception. 
Figure 4 shows the percentages of patients who had signifi-
cant difficulties with postoperative glare, halos, starburst, 
ghosting/double vision, or dry eyes. Between 10.7% and 
17.9% (depending on the type of phenomena) of patients who 
felt they were not properly consented for their procedure had 
severe postoperative difficulties with visual symptoms or dry 
eyes, whereas only between 0.7% and 2.3% of patients had 
significant difficulties in the group of patients who indicated 
they were “consented properly”.
One month postoperative difficulties patients 
experienced with tasks described in questions 7–9 (night 
driving, near vision, and distance activities) had also a 
significant impact on consent quality perception and were 
responsible for 3.7% of the variance explained by the 
model. Figure 5 shows the percentage of patients who had 
a lot of difficulties or were unable to perform activities 
because of their vision. A significantly higher proportion 
of patients (up to 25.7%) who were not satisfied with con-
sent quality experienced postoperative difficulty with one 
of these tasks.
One-month postoperative binocular UDVA was also a 
significant predictor of consent satisfaction, accountable for 
4.6% of the variance in our multivariate model. As an indica-
tion of this relationship, 93.5% of all “consented properly” 
patients had postoperative binocular UDVA 20/20 or better, 
whereas this percentage was only 85.0% for patients who felt 
they were not properly consented.
Change between preoperative and postoperative CDVA 
had a very slight (1.5% of the explained variance), but 
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Figure 2 Postoperative difficulties with various tasks: patients who had a remote consent discussion with their surgeon vs patients who had a face-to-face discussion in the clinic. 
Notes: (A) laser vision correction patients. (B) refractive lens exchange patients.
statistically significant impact on the model. As little as 0.9% 
of all “consented properly” patients had CDVA reduced 
by $2 lines at the 1-month postoperative visit in either eye 
and this number was 2.1% for patients who felt they were 
not properly consented.
Satisfaction with the surgeon’s approach (questions 1 
and 2, 2.9% of the explained variance) was also a minor but 
statistically significant factor in the regression model. Of all 
the “consented properly” patients, 83.8% were “very satis-
fied” with the surgeon’s care, while only 65.2% of patients 
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Table 5 results of multivariate regression analysis to predict outcomes of question 3: “Do you feel you were properly consented for 
surgery?” (R2=0.33, P,0.0001)
Independent variable Univariate, 
P-value
Multivariate, 
P-value
Model 
contribution (%)
age at treatment .0.05 – –
gender .0.05 – –
Consent: in-clinic vs remote 0.04* .0.05 –
number of days between consent and surgery day .0.05 – –
Type of surgery (lVC or rle) .0.05 – –
Preoperative sphere .0.05 – –
Preoperative cylinder .0.05 – –
Preoperative CDVa .0.05 – –
Postoperative sphere .0.05 – –
Postoperative cylinder 0.0003* .0.05 –
Postoperative binocular UDVa ,0.0001* ,0.0001* 4.6
Change in CDVa ,0.0001* 0.003* 1.5
Day 1 surgeon care and questions (questions 1 and 2) ,0.0001* ,0.0001* 2.9
Month 1 satisfaction (question 4) ,0.0001* ,0.0001* 80.4
Month 1 impact of eyesight on various activities (questions 7–9) ,0.0001* ,0.0001* 3.7
Month 1 dry eyes (question 6) ,0.0001* 0.01* 1.0
Month 1 visual symptoms (starburst, glare, halo, ghosting/double vision; question 6) ,0.0001* ,0.0001* 5.8
Note: *Statistically significant.
Abbreviations: CDVa, corrected distance visual acuity; lVC, laser vision correction; rle, refractive lens exchange; UDVa, uncorrected distance visual acuity.
Figure 3 Postoperative satisfaction with visual acuity for patients who felt they were properly consented for surgery and those who did not feel so.
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were “very satisfied” in the group of “not consented properly” 
patients. A similar relationship was observed in question 2: 
82.5% of “consented properly” patients and 61.7% of “not 
consented properly” patients were “very satisfied” with their 
surgeon answering all their questions.
The type of consent (in-clinic vs remote) was a sta-
tistically significant factor in the univariate model, with 
in-clinic patients being less satisfied with the consent process 
compared to remote patients. However, consent type had no 
impact on the patient’s perception of consent quality in the 
multivariate model.
Discussion
In our study population, the majority of LVC patients 
and approximately half of the RLE patients preferred a 
telemedicine consent approach with their surgeon. Remote 
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Figure 4 Postoperative difficulties with optical side effects compared between patients who indicated they were “properly consented” vs those who indicated they were “not 
properly consented” for their refractive procedure. “Significant difficulty”: patients who scored 6 or 7 on a scale between 1 (= no difficulty) and 7 (= severe difficulty).
Figure 5 Postoperative visual difficulties with various tasks based on patient’s perception of consent quality.
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consenting has many advantages for both – surgeon and the 
patient. Surgeons can provide consultations with flexible time-
tables and locations, even from the comfort of their home.2,10 
Furthermore, teleophthalmology can provide significant sav-
ings in time and travel expenses for patients, which could 
be the reason why it was mostly preferred by the younger 
population of patients, who may have busier schedules. Previ-
ous studies found good agreement between the diagnosis and 
management decisions by teleophthalmology compared to 
the diagnosis and management decisions in eye clinics.2,5,6,11,12 
This is mostly because diagnostic imaging and measurements 
play an important role in ophthalmology4 and these can be 
easily transferred via telemedicine and help in making a 
diagnosis or deciding on the suitability of candidates for 
surgery. In our consenting approach, however, the patient 
is always clinically examined by an ophthalmologist and 
the final decision to proceed with surgery is always made 
by the treating surgeon.
In this study, we compared satisfaction of patients who 
opted for the telemedicine approach and those who preferred 
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to meet their surgeon personally ahead of the surgery day. 
We found similar satisfaction with the consent process. In 
the LVC group, 97.5% of in-clinic patients and 98.3% of 
remote patients indicated that they were properly consented 
for surgery (P=0.04). In the RLE group, 97.6% of in-clinic 
and 97.9% of remote patients stated their consent process 
for surgery was adequate (P=0.47). The slight statistically 
significant difference in the LVC group is most likely due to 
the difference in clinical data between the two groups (eg, in-
clinic patients were slightly older and had more challenging 
preoperative refractive errors), which is the reason why it is 
necessary to apply a multivariate model to find real factors 
affecting satisfaction with consent quality.
Similar to our previous publication,8 we found that the 
major factor leading to dissatisfaction with consent quality 
is not the actual consent type, but an unsatisfactory outcome. 
The major factor affecting perception of consent quality was 
the satisfaction with postoperative vision, and it was respon-
sible for 80.4% of the variance explained by our multivari-
ate model. Of all “not consented properly” patients, 32.5% 
were dissatisfied with vision, whereas as little as 2.6% of 
patients were dissatisfied with vision if they felt their consent 
process was adequate. Other, also statistically significant, 
factors in the model were difficulties with postoperative 
visual phenomena, dry eyes, difficulties with tasks related 
to night driving, distance and close-up vision, postoperative 
binocular UDVA, and change in CDVA. All these suggest 
that an unsatisfactory postoperative outcome leads patients 
to believe that they were not properly consented. Satisfac-
tion with surgeon care and surgeons answering questions 
was also a minor, but statistically significant factor in the 
model (2.9% of the explained variance); however, the type 
of consent (remote or in-clinic) had no effect on the patient’s 
perception of consent quality. It is also important to note 
that there were patients who were satisfied with their visual 
outcomes but dissatisfied with the consent process. These 
were perhaps patients who were genuinely dissatisfied with 
their consent due to a combination of various factors (such as 
delay in getting an appointment, unhappy with the surgeon’s 
approach, unhappy with service received from the local 
clinic, long waiting time in the clinic), but still appreciated 
the visual gain from their refractive surgery. However, the 
proportion of patients who were dissatisfied with the consent 
process in our cohort was small (~2% of all patients included 
in this study).
Inadequate consenting process has been cited as a major 
factor in ophthalmology malpractice suits,13–17 but it is hardly 
ever the primary cause of litigation.18 It is the poor outcome 
that primarily leads to litigation in ophthalmology, with the 
consent process being a secondary factor in claims. Patients 
have been shown to process information selectively and 
tend to retain only the facts that are in favor of their deci-
sion to proceed with surgery.19–21 They often disregard or 
even deny hearing the risks and adverse events associated 
with their refractive surgery.19–21 To help address this issue, 
various forms of consenting tools have been proposed to 
improve the retention of consent information. These mostly 
consist of a combination of written, verbal, and audiovisual 
information22–28 and can significantly contribute to patients 
understanding of their medical condition and the proposed 
surgical procedures.29–33
The consenting process discussed here is multistep and 
involves written, spoken, and audiovisual delivery of the 
risks, benefits, and alternatives of surgery. Patients first 
see a refractive optometrist in their local clinic and have a 
discussion regarding potential procedures. They then watch 
a video, which reiterates the information provided by the 
optometrist, and are provided a written consent form. Dur-
ing the telephone discussion, the surgeon again discusses 
the risks and benefits of surgery, reviews the information 
recorded by the optometrist, ensures that the patient can 
provide informed consent, and answers all questions. The 
consent process culminates in signing the consent form, 
where the points of discussion are reiterated, and the patient 
confirms an understanding of the presented information.
Based on our multivariate model outcomes, we believe that 
a telemedicine surgeon discussion is essentially equivalent to 
a face-to-face approach. In fact, telemedicine consenting is 
increasingly used in various fields of medicine34,35 and results 
in high patient satisfaction and significant cost and time 
savings. Teleconsent was found to combine the convenience 
and accessibility of obtaining consent remotely with the 
confidence and value of in-person approach.34 Previous 
studies found no differences in comprehension and patient-
reported understanding when comparing telemedicine and 
face-to-face approaches for delivering informed consent.35
Our study has a few limitations. It is retrospective and 
the regression model is based on 1-month outcomes, when 
the healing process may not be completed in all patients. 
It is also possible that most of the symptoms and side effects 
subside over time and both CDVA and UDVA improve. 
For that reason, patients might change their opinion about 
consent and satisfaction with vision at later follow-ups. 
However, we feel it is appropriate to ask patients about their 
experience with the consenting process at early follow-ups, 
which are attended by the majority of patients. Another 
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advantage of using a 1-month postoperative questionnaire 
is that patients already experience outcomes of their proce-
dure, but still have some recollection of their preoperative 
consent information. The questionnaire we used in our 
study has been previously successfully used in many large 
population studies.8,36–38 Another possible limitation of the 
study is the bias in patient’s selection of consent type. There 
might have been lots of factors that affected the patient’s 
decision to proceed with remote consent, such as work com-
mitments, lifestyle, geographical distance from the nearest 
clinic, etc. However, the number of patients dissatisfied with 
the consent process was so low in this study that we believe 
our consent process (regardless of the type) is adequate and 
comprehensive.
Conclusion
In conclusion, we believe that remote consenting when 
utilized as part of a multimodal consent approach for elective 
refractive surgery can provide patients with an equivalent 
quality of information as meeting the surgeon person-
ally before the day of their procedure. The telemedicine 
approach to consenting was eagerly accepted by patients 
and resulted in high satisfaction. As previously suggested in 
the literature, a perceived poor outcome is the major cause 
of dissatisfaction with the consenting process. Reiterat-
ing the risks and increasing the patient’s understanding of 
surgery is one of the most important steps in consenting for 
elective procedures.
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